ONEMAP Trademark Application TM79442497 Published

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 20th, 2026

Detected March 25th, 2026

Summary

The USPTO has published the ONEMAP trademark application (TM79442497) for services related to medical testing, diagnosis, and treatment, as well as software and database services for biological, chemical, and medical analysis. The application was published for opposition on March 20, 2026.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application TM79442497 for the mark ONEMAP. This publication is for opposition and indicates that the application has passed initial examination and is now open to challenges from third parties. The application covers a broad range of services including single-cell medical testing and analysis for cancer prognosis, diagnosis, and treatment, as well as diagnostic services for other diseases. It also includes software development, SaaS, database management, and data processing services specifically for biological, chemical, and medical analysis, diagnostics, and clinical trials.

This publication is a procedural step in the trademark registration process. While it does not impose new compliance obligations on regulated entities, it is relevant for companies operating in the medical diagnostics, biotechnology, and health tech sectors. Competitors or interested parties have a period to oppose the registration of this mark. The filing date for this application was August 1, 2025, and it was published for opposition on March 20, 2026.

Source document (simplified)

← USPTO Trademark Applications

ONEMAP

Published for Opposition TM79442497 Kind: published Mar 20, 2026

Abstract

Single-cell medical testing and analysis services for cancer prognosis, diagnosis and treatment as well as for diagnosis or treatment of other diseases; medical services; diagnostic services, namely, medical diagnostic testing for cancer as well as for other diseases and disorders; medical tests for diagnostic or treatment purposes; medical testing for the diagnosis and treatment of persons; laboratory analysis services relating to the treatment of persons; medical services in the field of oncology and other medical fields; provision of medical information in the field of health; providing screening services for cancer and other diseases, namely, providing medical diagnostic testing services consisting essentially of chemical analysis and use of bioinformatics tools for cancer screening; provision of medical information collected and analyzed for the purpose of diagnosis or treatment of cancer and other diseases and disorders; provision of medical data/information intended for healthcare professionals.; Design, development, installation, updating, maintenance of software; Software as a Service [SaaS]; design and development of databases, conducting of scientific and technical studies; scientific and technological services as well as research and design services relating thereto; development and testing of methods and algorithms; electronic data storage; hosting of databases; all the aforesaid services being in the fields of biological and chemical analyses, medical diagnostics and clinical trials.; Database management; collection of data; data systematization in computer databases; provision of data; data analysis, namely, scientific data analysis; compilation of information in computer databases; services for gathering data in computer databases; systematization of information in computer databases; data processing services; updating of data and metadata in computer databases; subscriptions to database services by telecommunications; all the aforesaid services in the fields of biological and chemical analyses, medical diagnostics and clinical trials.; Software and software application for biological, chemical and medical analysis, software and software applications for medical diagnosis; biological, chemical and medical databases.